Han B, Comptom WM, Blanco C, Crane E, Lee J, Jones CM. Prescription opioid use, misuse, and use disorders in US adults: 2015 national survey on drug use and health. Ann Intern Med. 2017;167(5):293–301.

Article  Google Scholar 

Bell J, Strang J. Medication treatment of opioid use disorder. Biol Psychiatry. 2020;87(1):82–8.

Article  CAS  Google Scholar 

Lander LR, Zheng W, Hustead JD, Mahoney JJ, Berry JH, Marshalek P, et al. Long-term treatment retention in West Virginia’s comprehensive opioid addiction treatment (COAT) program. J Neurol Sci. 2020;411:116712.

Article  CAS  Google Scholar 

National academies of sciences engeneering and medicine. Medications for opioid use disorder save lives. 2019.

Hser Y, Hoffman V, Grella C, Anglin MD. A 33-year follow-up of narcotic addicts. Arch Gen Psychiatry. 2001;58(5):503–8.

Article  CAS  Google Scholar 

National institute on drug abuse. Methadone and buprenorphine reduce risk of death after opioid overdose. New releases. 2018 .  https://www.drugabuse.gov/news-events/news-releases/2018/06/methadone-and-buprenorphine-reduce-risk-of-death-after-opioid-overdose. Accessed 1 Jul 2020.

Substance abuse and mental health services administration (SAMHSA). MAT medications, counseling, and related conditions. 2020 .  https://www.samhsa.gov/medication-assisted-treatment/medications-counseling-related-conditions. Accessed 1 Jul 2020.

Vogel M, Nordt C, Dürsteler KM, Lang UE, Seifritz E, Krausz M, et al. Evaluation of medication-assisted treatment of opioid dependence-the physicians’ perspective. Drug Alcohol Depend. 2016;164:106–12.

Article  Google Scholar 

Korthuis PT, McCarty D, Weimer M, Bougatsos C, Blazina I, Zakher B, et al. Primary care–based models for the treatment of opioid use disorder. Ann Intern Med. 2017;166:268–78.

Article  Google Scholar 

Sheppard AB, Young JC, Davis SM, Moran GE. Perceived ability to treat opioid use disorder in West Virginia. J Appalach Heal. 2021;3(2):32.

Google Scholar 

Richard EL, Schalkoff CA, Piscalko HM, Brook DL, Sibley AL, Lancaster KE, et al. “You are not clean until you’re not on anything”: perceptions of medication-assisted treatment in rural Appalachia. Int J Drug Policy. 2020. https://doi.org/10.1016/j.drugpo.2020.102704.

Article  Google Scholar 

Salvador JG, Bhatt SR, Jacobsohn V, Maley LA, Alkhafaji RS, Rishel Brakey H, et al. Feasibility and acceptability of an online ECHO intervention to expand access to medications for treatment of opioid use disorder, psychosocial treatments and supports. Subst Abus. 2020;19:1–8.

Google Scholar 

Lister JJ, Weaver A, Ellis JD, Himle JD, Ledgerwood DM. A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the United States. Am J Drug Alcohol Abuse. 2020;46(3):273–88.

Article  Google Scholar 

West Virginia department of health and human services. Division of primary care. state agency directory/online services.  https://dhhr.wv.gov/dpc/primarycare/Pages/default.aspx. Accessed 19 Oct 2022.

The Robert graham center. Policy studies in family medicine and primary care. West Virginia state profile of primary care workforce and social determinants of health. https://www.aafp.org/dam/rgc/documents/publications-reports/monographs-books/WestVirginiaPrimaryCareSocialDetHealth.pdf. Accessed 29 Mar 2022.

Madden EF. Intervention stigma: how medication-assisted treatment marginalizes patients and providers. Soc Sci Med. 2019;232:324–31.

Article  Google Scholar 

West Virginia clinical and translational science institute. The West Virginia practice-based research network . Network membership as of 4/2019. 2019. https://www.wvctsi.org/media/12947/member-info-sheet-4-2019.pdf. Accessed 29 Mar 2022.

West Virginia clinical and translational science institute. WVPBRN CORE survey. resources and services. https://www.wvctsi.org/programs/community-engagement-outreach/practice-based-research-network/wvpbrn-core-survey/. Accessed 2 Feb 2022.

Knudsen HK, Abraham AJ, Oser CB. Barriers to the implementation of medication-assisted treatment for substance use disorders: the importance of funding policies and medical infrastructure. Eval Program Plann. 2011 Nov;34(4):375–81.

Article  Google Scholar 

Bauer MS, Damschroder L, Hagedorn H, Smith J, Kilbourne AM. An introduction to implementation science for the non-specialist. BMC Psychol. 2015. https://doi.org/10.1186/s40359-015-0089-9.

Article  Google Scholar 

Foster SD, Lee K, Edwards C, Pelullo AP, Khatri UG, Lowenstein M, et al. Providing incentive for emergency physician X-Waiver training: an evaluation of program success and postintervention buprenorphine prescribing. Ann Emerg Med. 2020;76(2):206–14.

Article  Google Scholar 

Olsen Y, Fitzgerald RM, Wakeman SE. Overcoming barriers to treatment of opioid use disorder. JAMA. 2021;325(12):1149–50.

Article  Google Scholar 

Andraka-Cristou B, Totaram R, Randall-Kosich O. Stigmatization of medications for opioid use disorder in 12-step support groups and participant responses. Subst Abus. 2022;43(1):415–24.

Article  Google Scholar 

Tiako MJN, Mszar R, Brooks 2nd C, Mahmood SU, Bin, Mori M, Vallabhajosyula P, et al. Cardiac surgeons’ practices and attitudes toward addiction care for patients with substance use disorders. Subst Abus. 2022;43(1):206–11.

Article  Google Scholar 

Paquette CE, Syvertsen JL, Pollini RA. Stigma at every turn: health services experiences among people who inject drugs. Int J Drug Policy. 2018;57:104–10.

Article  Google Scholar 

Salsitz E, Wiegand T. Pharmacotherapy of opioid addiction: “putting a real face on a false demon. J Med Toxicol. 2016;12(1):58–63.

Article  CAS  Google Scholar 

Bacsu J-D, Johnson S, O’connell ME, Viger M, Muhajarine N, Hackett P, et al. Stigma reduction interventions of dementia: a scoping review. Can J Aging. 2021;13:1–11.

Google Scholar 

Kohrt BA, Turner EL, Rai S, Bhardwaj A, Sikkema KJ, Adelekun A, et al. Reducing mental illness stigma in healthcare settings: proof of concept for a social contact intervention to address what matters most for primary care providers. Soc Sci Med. 2020;250:112852.

Article  Google Scholar 

Martínez-Martínez C, Sanchez-Martinez V, Sales-Orts R, Dinca A, Richart-Martinez M, Ramos-Pichardo JD. Effectiveness of direct contact intervention with people with mental illness to reduce stigma in nursing students. Int J Ment Health Nurs. 2019;28(3):735–43.

Article  Google Scholar 

Mittal D, Owen RR, Ounpraseuth S, Chekuri L, Drummond KL, Jennings MB, et al. Targeting stigma of mental illness among primary care providers: findings from a pilot feasibility study. Psychiatry Res. 2020;284:112641.

Article  Google Scholar 

Clinton AJ, Pollini RA. Using positive empathy interventions to reduce stigma toward people who inject drugs. Front Psychol. 2021;12:616729.

Article  Google Scholar 

Coleman T, Lewis S, Hubbard R, Smith C. Impact of contractual financial incentives on the ascertainment and management of smoking in primary care. Addiction. 2007;102(5):803–8.

Article  Google Scholar 

Guttmann A, Saunders NR, Kumar M, Gandhi S, Diong C, MacCon K, et al. Implementation of a physician incentive program for 18-month developmental screening in ontario. Canada J Pediatr. 2020;226:213-220.e.1.

Article  Google Scholar 

Staples JA, Liu G, Brubacher JR, Karimuddin A, Sutherland JM. Physician financial incentives to reduce unplanned hospital readmissions: an interrupted time series analysis. J Gen Intern Med. 2021;36(11):3431–40.

Article  Google Scholar 

Swami M, Scott A. Impact of rural workforce incentives on access to GP services in underserved areas: evidence from a natural experiment. Soc Sci Med. 2021;281:114045.

Article  Google Scholar